ASCRO adds non-profit organization to the radiation oncology field

NewsGuard 100/100 Score

The founding members of the American Society of Clinical Radiation Oncology, ASCRO, are very pleased to announce the addition of this professional non-profit organization to the radiation oncology field. ASCRO is primarily dedicated to acquiring a "Provider Status" for clinical radiation oncology physicists.

"ASCRO believes that the quality of patient care will be significantly enhanced when clinical radiation oncology physicists are given Provider Status. Such a status will allow them to make professional decisions based solely on the best interest of cancer patients," said Dr. Nabil Adnani, ASCRO's President and founding member. "By joining ASCRO in large numbers, clinical radiation oncology physicists will ensure, and for the first time in history, their true place as medical professionals," Dr. Adnani went on to say.

"Finally, a long overdue society is born. Clinical Radiation Oncology Physicists now have an organization they can call their own," said Dr. Ivan Brezovich, ASCRO's Chairman and founding member.

ASCRO will work with existing organizations and will seek advice from more established professional societies such as the American Association of Physicists in Medicine (AAPM) and the American Society for Therapeutic Radiation Oncology (ASTRO) in its efforts to obtain a "Provider Status" for its members.

SOURCE American Society of Clinical Radiation Oncology (ASCRO)

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expanding research and clinical options for children with cancer